CLGN and CPT.MU Related Headlines
Go Back- CollPlant Biotechnologies Launches Redesigned Corporate Website
- CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex
- CollPlant announces $2.0 million registered direct offering
- COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING
- First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk
- CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler
- CollPlant Expands the Distribution of its VergenixSTR Product in Europe
- CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
- COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS
- COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES
CLGN and CPT.MU Related Press Releases
Go Back- CollPlant Biotechnologies Launches Redesigned Corporate Website
- CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex
- COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING
- First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk
- CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler
- CollPlant Expands the Distribution of its VergenixSTR Product in Europe
- CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
- COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS
- COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES
